DCAT Week '12 Biologics Forum & Networking Reception

Inside the mHealth Revolution with Welch Allyn: Realizing the Potential of Connected Devices
After launching a line of connected devices, Welch Allyn immediately viewed it as an oppor
Drug Development: An Overview of the Regulated Clinical Trials Process Used to Bring a New Drug to Market
Join us for a one-hour overview of the regulated clinical trials process used to bring a n
Special Studies in Cancer Patients: AME and Cardiac Safety
FierceBiotech Editor John Carroll will moderate an expert panel discussion exploring how c
Webinar: Next Gen Sequencing from FFPE Samples
Next generation sequencing (NGS) technologies hold enormous promise to advance personalize

Tools

Location:

New York City

Date:

Mar 14

Representatives from the FDA, Genentech, and Pfizer will discuss the regulatory filing pathway for biosimilars, key global investment drivers for the biologic-based drug industry, and raw material related risk for biopharmaceutical-based manufacturing processes. Learn more.

Share & Save

Digg
Reddit

Most Popular Stories

Webinars

Featured Jobs

Events

Free Newsletter

Popular Topics

Whitepapers

DCAT Week '12 Biologics Forum & Networking Reception

THE FIERCEMARKETS NETWORK